Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

10.22 -0.03 (-0.29%)

Delayed Quote Updated: 1:01 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Churchill Capital Corp XI - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide ↗

May 07, 2021

Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93. The U.S. has the...

Via Benzinga

Topics Stocks

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 07, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Why ChemoCentryx Shares Are Plunging Today ↗

May 07, 2021

ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval on its Avacopan in ANCA-Associated...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; US Adds Only 266,000 Jobs In April ↗

May 07, 2021

Following the market opening Friday, the Dow traded up 0.40% to 34,686.06 while the NASDAQ rose 1.16% to 13,790.95. The S&P also rose, gaining 0.69% to 4,230.68. The U.S. has...

Via Benzinga

Topics Stocks

56 Stocks Moving In Friday's Mid-Day Session ↗

May 07, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321. Regional Health Properties, Inc. (NYSE: RHE) gained 43% to $21.40 after dropping 23% on Thursday....

Via Benzinga

Analysts React To FDA AdCom Vote On ChemoCentryx's Avacopan, Stock Plunges ↗

May 07, 2021

Yesterday, the FDA’s Arthritis Advisory Committee panelists went through cloudy data while complaining about the design of the Phase 3 trial for ChemoCentryx Inc...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 7, 2021 ↗

May 07, 2021

Upgrades Loop Capital upgraded the previous rating for Roku Inc (NASDAQ:ROKU) from Hold to Buy. In the first quarter, Roku showed an EPS of $0.54, compared to $0.45 from...

Via Benzinga

ChemoCentryx Stock Loses Half Its Value; Is This The Final Nail For Its Drug? ↗

May 07, 2021

A panel of experts was split Thursday on whether to recommend approval for ChemoCentryx's autoimmune disease drug — and CCXI stock plummeted Friday.

Via Investor's Business Daily

10 Biggest Price Target Changes For Friday ↗

May 07, 2021

Stifel boosted Wayfair Inc. (NYSE: W) price target from $200 to $280. Wayfair shares rose 1.7% to $290.91 in pre-market trading. RBC Capital raised ViacomCBS Inc. (NASDAQ: VIAC...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 07, 2021

Gainers Assertio Holdings (NASDAQ:ASRT) shares moved upwards by 32.42% to $0.66 during Friday's pre-market session. The company's market cap stands at $114.5...

Via Benzinga

Adcomm Split On FDA Approval For ChemoCentryx's Vasculitis Candidate ↗

May 07, 2021

The FDA’s Arthritis Advisory Committee voted 10 for and 8 against the approval of ChemoCentryx Inc’s (NASDAQ: CCXI) investigational drug...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

CHEMOCENTRYX SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against ChemoCentryx, Inc. - CCXI

May 06, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors

May 06, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 06, 2021

From The Schall Law Firm

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors

May 06, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors

May 06, 2021

From Law Offices of Howard G. Smith

Via Business Wire

ChemoCentryx Investors With Losses Greater Than $100,000 - Kehoe Law Firm, P.C. Securities Class Action Investigation

May 06, 2021

Class Action Investigation On Behalf Of ChemoCentryx Investors With Significant Losses

Via EIN Presswire

Topics Fraud Lawsuit

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

May 06, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm

May 06, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages ChemoCentryx, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – CCXI

May 06, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

May 05, 2021

From The Schall Law Firm

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 05, 2021

Gainers Chiasma (NASDAQ:CHMA) stock moved upwards by 39.04% to $3.95 during Wednesday's pre-market session. The market value of their outstanding shares is at $228.4...

Via Benzinga

64 Biggest Movers From Yesterday ↗

May 05, 2021

Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug...

Via Benzinga

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ChemoCentryx, Inc. and Encourages Investors with Losses to Contact the Firm

May 04, 2021

From The Schall Law Firm

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 04, 2021

Gainers Obalon Therapeutics (NASDAQ:OBLN)...

Via Benzinga

Why ChemoCentryx Stock Crashed Today ↗

May 04, 2021

The FDA's briefing documents for an advisory committee don't appear to bode well for avacopan's chances of approval.

Via The Motley Fool

Why Cocrystal Pharma, Chemocentryx, Neuronetics And BioLineRx Are Moving Today ↗

May 04, 2021

Cocrystal Pharma, Inc. (NASDAQ: COCP), ChemoCentryx, Inc. (NASDAQ: CCXI), Neuronetics, Inc. (NASDAQ: STIM) and BioLineRx Ltd. (NASDAQ: BLRX) are among the biggest health care...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.